Saol Therapeutics
is a Georgia-based pharmaceutical company that provides therapies for CNS disorders such as pain management, spasticity, and orphan diseases... Read moreSaol Therapeutics
is a Georgia-based pharmaceutical company that provides therapies for CNS disorders such as pain management, spasticity, and orphan diseases... Read more
News
Jan 28, 2025
StreetInsider
Press Release: Saol Therapeutics : Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency
Oct 31, 2024
Pharmabiz
Saol Therapeutics: Saol Therapeutics announces positive results from the SL1002 RAISE Limb Spasticity Trial
Mar 16, 2023
BioSpace
Saol Therapeutics: Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric Cancers
Oct 04, 2022
Markets Insider
Saol Therapeutics: Saol Therapeutics Announces Enrollment Achievement in Pivotal Phase 3 Trial for Rare Mitochondrial Disease - Pyruvate Dehydrogenase Complex Deficiency (PDCD)
May 04, 2022
Clinical Trials Arena
Saol Therapeutics: Saol doses first subject in Phase II limb spasticity treatment trial
Apr 26, 2022
BioSpace
Saol Therapeutics: Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease
Mar 01, 2022
Genomeweb
Saol Therapeutics: Saol Therapeutics, GeneDx Partner to ID Patients With Rare Mitochondrial Disease
Jan 13, 2022
Drug Store News
Saol Therapeutics: Amneal to acquire Saol Therapeutics' Baclofen franchise
Jan 05, 2022
NJBIZ
Saol Therapeutics: Amneal acquires Saol Therapeutics Baclofen franchise
Jan 05, 2022
Nasdaq
Saol Therapeutics: Amneal To Buy Saol's Baclofen Franchise For $83.5 Mln
Saol Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10